232 related articles for article (PubMed ID: 26087197)
21. Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration.
Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Liu Y; Qu X
Mol Med Rep; 2012 Feb; 5(2):580-4. PubMed ID: 22101248
[TBL] [Abstract][Full Text] [Related]
22. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
23. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
[TBL] [Abstract][Full Text] [Related]
24. Role of the RANK/RANKL pathway in breast cancer.
Kiesel L; Kohl A
Maturitas; 2016 Apr; 86():10-6. PubMed ID: 26921922
[TBL] [Abstract][Full Text] [Related]
25. Cbl-b regulates the sensitivity of cetuximab through ubiquitin-proteasome system in human gastric cancer cells.
Yu P; Fan Y; Qu X; Zhang J; Song N; Liu J; Liu Y
J BUON; 2016; 21(4):867-873. PubMed ID: 27685907
[TBL] [Abstract][Full Text] [Related]
26. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells.
CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L
Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413
[TBL] [Abstract][Full Text] [Related]
27. Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis.
Jeganathan N; Predescu D; Zhang J; Sha F; Bardita C; Patel M; Wood S; Borgia JA; Balk RA; Predescu S
Mol Cancer; 2016 Sep; 15(1):59. PubMed ID: 27629044
[TBL] [Abstract][Full Text] [Related]
28. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance.
Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL
Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312
[TBL] [Abstract][Full Text] [Related]
29. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
Nihal M; Wood GS
Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
31. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
32. Cbl-b and PI3K/Akt pathway are differently involved in oxygen-glucose deprivation preconditioning in PC12 cells.
Zhang W; Yu H; Zou W; Wang YF; Liang XF; Zhang B; Kong JJ; Li P; Zhang DD; Yin L
Chin Med J (Engl); 2013 Nov; 126(21):4132-8. PubMed ID: 24229686
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
[TBL] [Abstract][Full Text] [Related]
34. YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
Chang LC; Lin HY; Tsai MT; Chou RH; Lee FY; Teng CM; Hsieh MT; Hung HY; Huang LJ; Yu YL; Kuo SC
Br J Pharmacol; 2014 Sep; 171(17):4010-25. PubMed ID: 24697523
[TBL] [Abstract][Full Text] [Related]
35. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
Hirsch DS; Shen Y; Wu WJ
Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
[TBL] [Abstract][Full Text] [Related]
36. RANKLed by the Complexity of Signaling in Breast Cancer Metastasis to the Brain.
Wang K; Hackney JR; Siegal GP; Wei S
Clin Breast Cancer; 2020 Oct; 20(5):e569-e575. PubMed ID: 32381383
[TBL] [Abstract][Full Text] [Related]
37. Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration.
Hsu CJ; Lin TY; Kuo CC; Tsai CH; Lin MZ; Hsu HC; Fong YC; Tang CH
J Cell Biochem; 2010 Sep; 111(1):138-47. PubMed ID: 20506523
[TBL] [Abstract][Full Text] [Related]
38. Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma.
Steven A; Leisz S; Fussek S; Nowroozizadeh B; Huang J; Branstetter D; Dougall WC; Burchardt M; Belldegrun AS; Seliger B; Pantuck A; Kroeger N
Urol Oncol; 2018 Nov; 36(11):502.e15-502.e24. PubMed ID: 30170981
[TBL] [Abstract][Full Text] [Related]
39. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
[TBL] [Abstract][Full Text] [Related]
40. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]